Therefore, it is biologically plausible that the putative risk genotypes in PTEN/AKT/mTOR axis are implicated in the progression of PCa, indicating that this pathway is an exciting and rational molecular target for therapy in PCa. Here, PTEN is linked to posterior cortical atrophy.